Navigation Links
Novel RNA interference screening technique identifies possible path for malignant glioma treatment
Date:5/25/2010

WORCESTER, Mass. Researchers at the University of Massachusetts Medical School report in the journal Nature Medicine on a cellular pathway in the deadly brain cancer malignant glioma, a pathway essential to the cancer's ability to grow and a potential target for therapy that would stop the cancer's ability to thrive.

In the paper "A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications," appearing this week as an Advanced Online Publication, UMass Medical School Professor Michael R. Green, MD, PhD, and colleagues use a genome-wide RNAi screening tool to identify a dozen genes that affect the function of a crucial protein necessary for glioma cells to grow; further research found a key pathway that appears in laboratory cultures and mouse models to be susceptible to two cancer drugs already in use for other types of cancer.

A hallmark of cancer is uncontrolled cell growth, often caused by overexpression of genes that help cells survive, or underexpression of those genes that induce normal cell death. Genes that are expressed highly in cancer cells and are essential for their survival are appealing targets for drug therapy.

Green's lab has in recent years developed a clever way of scanning the genome to identify genes that appear to promote the natural process of programmed cell death called "apoptosis", or that inhibit the growth of cells; Green and colleagues used a technique called genome-wide RNA interference screeningto identify novel genes that regulate the expression of a transcription factor called ATF5 in malignant glioma cells. The discovery of at least one previously unknown genetic pathway that appears to regulate this key transcription factor, and the subsequent determination that the cancer drugs sorafenib and temozolomide inhibit glioma growth point to dramatic new possibilities for potential therapeutics and are exciting advanc
'/>"/>

Contact: Jim Fessenden
PublicAffairs@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel anti-malarial drug candidate found by UT Southwestern researchers
2. ASCO data highlight novel anti-cancer approach that exposes tumors to immune attack
3. Research identifies patterns of CD24, a novel biomarker for non-small cell lung carcinomas
4. Third European Novel Food Approval Received by Tahitian Noni International
5. Novel nanoparticles prevent radiation damage
6. Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women
7. Novel Method Eyed for Normalizing Blood Sugar
8. Novel Parkinson's Treatment Strategy Involves Cell Transplantation
9. MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010
10. Novel medical home program for pediatric patients, families cuts ER visits in half
11. Novel stroke treatment passes safety stage of UCI-led clinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Centurion Service Group, the world's largest medical ... used medical equipment. , The live auction will take place on Thursday, ... Lauderdale warehouse located at 5025 North Hiatus Road Sunrise, FL 33351. Anyone can participate ...
(Date:8/4/2015)... Orleans, LA (PRWEB) , ... August 04, 2015 ... ... Catholic institution of higher learning, announced today that its RN to BSN and ... programs have been awarded full accreditation through June 2020 from the Commission ...
(Date:8/4/2015)... ... August 04, 2015 , ... Please join us for the ... September 20th at Oneida Shores Park in Brewerton, NY. , Doris Connor was ... aneurysm at the young age of 59. Her family and friends have since become ...
(Date:8/4/2015)... ... , ... Following last month’s successful rollout of its client video series, ACE ... an Academic Setting, and The Importance of PVI Accreditation. , In The Benefits ... Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in Las Vegas, NV, Chandan ...
(Date:8/3/2015)... ... ... the pace of the economic recovery since the 2008 has been subject to much debate, ... the last six years. Unemployment has dropped from a 2009 high of 10 percent to ... in 2014, the U.S. stock market is at an all time high, and interest rates ...
Breaking Medicine News(10 mins):Health News:Medical Equipment Auction to Take Place in Fort Lauderdale 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 2Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4
... events and experiences in both youth and middle adulthood ... according to a new supplemental issue of the Journals ... Furthermore, the authors find that the processes of aging linked ... simultaneously, as part of the same set of processes. ...
... , WEDNESDAY, Aug. 31 (HealthDay News) -- Older, ... leaner menopausal women, a small, new study suggests. The ... not taking medication for those symptoms. The women,s ... were also measured, and a special skin monitor and electronic ...
... , WEDNESDAY, Aug. 31 (HealthDay News) -- Smoking ... new study finds. Researchers used ultrasound to assess the ... in 1,893 women and 1,694 men in Finland, Sweden, the ... lifetime of smoking was associated with thickening of the arterial ...
... Reporter , WEDNESDAY, Aug. 31 (HealthDay News) -- Caring for ... be hard enough, but long-distance caregiving, which is becoming more ... added burdens. By 2012, an estimated 14 million Americans ... new names: "seagulls" and "pigeons." These terms refer to ...
... (HealthDay News) -- ,Hand axes, picks and other stone tools ... were using advanced tool-making methods at least 300,000 years earlier ... found in East Africa are believed to have been made ... who appeared about 2 million years ago and disappeared about ...
... in the late 1960s and early 1970s used marshmallows and ... gratification. If they held off on the temptation to eat ... of the children resisted, others didn,t. A newly published ... that these differences remain: Those better at delaying gratification as ...
Cached Medicine News:Health News:Being Heavier May Mean Fewer Hot Flashes for Women Over 60 2Health News:For Many Americans, Caregiving a Long-Distance Burden 2Health News:For Many Americans, Caregiving a Long-Distance Burden 3Health News:40-year follow-up on marshmallow test points to biological basis for delayed gratification 2
(Date:8/3/2015)... CORAL SPRINGS, Florida , August 3, ... and development agreements between biotech companies, military ... biotech solutions & therapies with regards to ... to positive clinical enhancements for regenerative medicine ... with recent developments, partnerships and advancements in ...
(Date:8/3/2015)... Biosensors International Group, Ltd. ("Biosensors" or ... B20), a developer, manufacturer and marketer of innovative ... first fiscal quarter ended 30 June 2015 ("Q1 ... Developments: , Biosensors continued to ... driven by lower operating expenses and operational improvement. ...
(Date:8/3/2015)... Colo., Aug. 3, 2015  Array BioPharma Inc. ... the fourth quarter and full year of its ... Ron Squarer, Chief Executive Officer of Array, noted, "Binimetinib ... 3, are on track for regulatory submissions in ... BRAF-mutant melanoma and BRAF-mutant colorectal cancer further validate ...
Breaking Medicine Technology:Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12
... 2011 Generex Biotechnology Corporation (OTCBB: GNBT) ( www.generex.com ... investor update conference call for late November.  The purpose ... update on (i) the status of the Company,s efforts ... wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ), ...
... 24, 2011 Neuralstem, Inc. (NYSE Amex: CUR ... trial of the company,s spinal cord stem cells in the ... at Emory University in Atlanta, Georgia. The company announced that, ... Food and Drug Administration (FDA) has granted approval for the ...
Cached Medicine Technology:Generex Announces Investor Update Conference Call Planned for Late November 2Generex Announces Investor Update Conference Call Planned for Late November 3Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial 2Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial 3Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial 4
... manufactures two groups of flexible lighting products. ... non-sterile in three different sizes 5", 10", ... portion of the light). These lights are ... is needed., ,The second group of ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
Medicine Products: